Patient Education and Treatment Strategies Implemented at a Pharmacist-Managed Hepatitis C Virus Clinic

Bonnie Kolor, Pharm.D.


Pharmacotherapy. 2005;25(9):1230-1241. 

In This Article


More than 50% of patients with HCV infection achieve a sustained viral response when treated with peginterferon alfa-ribavirin combination therapy. The 2002 National Institutes of Health Consensus Statement concerning management of hepatitis C identifies all patients with HCV infection as potential candidates for treatment with combination therapy. Evaluation by a physician experienced in the use of combination therapy is recommended for all patients with HCV infection. However, successful treatment of these patients is facilitated by involvement of a multidisciplinary team of health care professionals, including the clinical pharmacist. Team members are skilled in areas such as patient education, administration of combination therapy, and monitoring and management of treatment-associated adverse events. Interventions carried out by pharmacists at HCV clinics provide critical support for patients with HCV while they adhere to combination therapy, thereby increasing their chances for a successful treatment outcome.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: